Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 26 fludarabine 16 Etoposide 15 Melphalan 13 romidepsin 12 Gemcitabine 11 Whole-Body Irradiation 10 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Doxorubicin 10 fludarabine phosphate 9 Rituximab 9 Lenalidomide 9 Cytarabine 9 Busulfan 9 pembrolizumab 8 Prednisone 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Bortezomib 8 Filgrastim 7 Carmustine 7 Brentuximab Vedotin 7 Biopsy 7 duvelisib 6 Tacrolimus 6 Specimen Handling 6 Dexamethasone 6 Bendamustine Hydrochloride 6 ruxolitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, T-Cell × Flavin-Adenine Dinucleotide × Clear all

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡